These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3955826)

  • 1. Quantification of cyclosporin G (NVa2 cyclosporin) by radioimmunoassay.
    Yatscoff RW; Jeffery JR
    Clin Chem; 1986 Apr; 32(4):700-1. PubMed ID: 3955826
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of cyclosporin G (Nva2-cyclosporin) concentrations measured in whole blood by monoclonal fluorescence polarization immunoassay, monoclonal radioimmunoassay, and HPLC.
    Annesley TM; Coombs RC; Orsulak PJ
    Clin Chem; 1993 Jun; 39(6):1050-3. PubMed ID: 8504536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sample preparation on cyclosporin G (NVA2-cyclosporin) concentration.
    Yatscoff RW; Jeffrey JR
    Clin Chem; 1987 Jul; 33(7):1257. PubMed ID: 3297425
    [No Abstract]   [Full Text] [Related]  

  • 4. High-performance liquid chromatographic analysis of cyclosporin G (Nva2-cyclosporine) in human blood.
    Annesley TM; Matz K; Leichtman AB
    Ther Drug Monit; 1992 Oct; 14(5):397-401. PubMed ID: 1448848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of cyclosporin G (NVa2 cyclosporin) in blood and plasma.
    Yatscoff RW; Honcharik N; Lukowski M; Thliveris J; Chackowsky P; Faraci C
    Clin Chem; 1993 Feb; 39(2):213-7. PubMed ID: 8432008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays.
    Yatscoff RW; Langman LJ; LeGatt DF
    Clin Chem; 1993 Jun; 39(6):1089-92. PubMed ID: 8504544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of metabolism in HepG2 cells upon treatment with cyclosporin A and Nva2-cyclosporin.
    Bäckman L; Appelkvist EL; Sundberg A; Teclebrhan H; Brunk U
    Exp Mol Pathol; 1991 Jun; 54(3):242-54. PubMed ID: 1647968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Nva2)-cyclosporine--less potent than cyclosporine A in rats with lung and heart transplants.
    Prop J; Hoyt EG; Jamieson SW
    Transplantation; 1987 Jul; 44(1):5-8. PubMed ID: 3111038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.
    Gunn HC; Ryffel B
    Clin Exp Immunol; 1986 May; 64(2):234-42. PubMed ID: 3742874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
    Gunn HC
    Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.
    Rosano TG
    Clin Chem; 1985 Mar; 31(3):410-2. PubMed ID: 3882273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The isolation, structural characterization, and immunosuppressive activity of cyclosporin G (NVa2-cyclosporine) metabolites.
    Copeland KR; Yatscoff RW
    Ther Drug Monit; 1991 Jul; 13(4):281-8. PubMed ID: 1780958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of cyclosporine A and Nva2-cyclosporine (cyclosporine G) in a rat renal allograft model.
    Grant D; Zhong R; Stiller C; Wallace C; Keown P; Duff J
    Transplantation; 1987 Jul; 44(1):9-12. PubMed ID: 3299927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of cyclosporine and NVa2-cyclosporine in dogs.
    Venkataramanan R; Todo S; Zaghloul I; Lynch S; Kam I; Ptachcinski RJ; Burckart GJ; Starzl TE
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1265-6. PubMed ID: 3274314
    [No Abstract]   [Full Text] [Related]  

  • 15. Canine liver transplantation under Nva2-cyclosporine versus cyclosporine.
    Todo S; Porter KA; Kam I; Lynch S; Venkataramanan R; DeWolf A; Starzl TE
    Transplantation; 1986 Mar; 41(3):296-300. PubMed ID: 3513388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of cyclosporin concentration in blood by radioimmunoassay].
    Duffek L; Dabasi G
    Orv Hetil; 1991 Feb; 132(5):239-42. PubMed ID: 1996207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay.
    Carruthers SG; Freeman DJ; Koegler JC; Howson W; Keown PA; Laupacis A; Stiller CR
    Clin Chem; 1983 Jan; 29(1):180-3. PubMed ID: 6336679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivatives of cyclosporin compatible with antibody-based assays: I. The generation of [125I]-labeled cyclosporin.
    Mahoney WC; Orf JW
    Clin Chem; 1985 Mar; 31(3):459-62. PubMed ID: 3971569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatography for cyclosporin measurement: comparison with radioimmunoassay.
    Plebani M; Masiero M; Paleari CD; Sciacovelli L; Faggian D; Burlina A
    J Chromatogr; 1989 Aug; 476():93-8. PubMed ID: 2777999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
    Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC
    J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.